December 18, 2025 — We applaud the federal government’s move to reschedule cannabis and recognize it as a meaningful milestone for an industry we have supported since its earliest days.
We chose to stand with cannabis operators, investors, and innovators at a time when many others would not. When the legal and regulatory landscape was uncertain, fragmented, and often hostile, we worked alongside our clients to navigate conflicting state and federal laws, build compliant business models, and manage significant regulatory and enforcement risk.
Rescheduling represents a long-overdue acknowledgment of what our clients have demonstrated for years: that cannabis can be operated responsibly, regulated effectively, and integrated into legitimate business frameworks.
This moment belongs to our clients. They persevered through uncertainty, limited access to capital, and evolving enforcement priorities—yet continued to operate with integrity and resilience. We are proud to celebrate this progress alongside them.
While rescheduling marks an important shift in federal policy, it is not the end of the regulatory journey. Significant legal, tax, banking, and compliance challenges remain, and the next phase of industry growth will demand experienced counsel with deep institutional knowledge.
We bring perspective that can only come from having advised the cannabis industry through its most challenging periods. Our experience is grounded in real-world problem-solving, not theory, and positions us to help clients adapt to—and benefit from—this evolving federal landscape.
Greenspoon Marder believed in this industry from the beginning, and we remain fully invested in its future. As the regulatory framework continues to evolve, we will continue advocating for sensible policy, protecting our clients’ interests, and supporting the long-term legitimacy and sustainability of the cannabis industry.
Click here to read the cannabis rescheduling Executive Order.